Literature DB >> 10361241

Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.

K Kemp1, M Kemp, A Kharazmi, A Ismail, J A Kurtzhals, L Hviid, T G Theander.   

Abstract

Peripheral blood mononuclear cells (PBMC) from patients who have recovered from visceral leishmaniasis often respond to Leishmania antigens in vitro by production of both IL-4, IFN-gamma and IL-10. In order to establish the cellular sources of these cytokines, we activated cells from individuals with a history of visceral leishmaniasis with Leishmania antigen for 6 days in culture, and identified cytokine production at the single-cell level by flow cytometry. The cytokines were only found in CD3+ cells and among these mainly within the CD4+ subset. The percentage of cytokine-producing cells was compared in Leishmania-activated PBMC cultures from the previous patients and from individuals living in a village where leishmaniasis does not occur. The percentage of IL-10- and IFN-gamma-containing cells was significantly higher in the previous patients than in the controls, indicating that Leishmania-specific T cells producing IL-10 and/or IFN-gamma had been expanded as a result of the infection. The cytokine-producing cells in the previous patients could be divided into three types: (i) cells producing IFN-gamma only; (ii) cells producing IL-4 only; and (iii) cells producing IFN-gamma and IL-10 simultaneously. The first and second group of cells can be described as Th1- and Th2-type cells, respectively. The third group could be a regulatory subset of T cells important for maintaining a balance between Th1- and Th2-type cells in these individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361241      PMCID: PMC1905302          DOI: 10.1046/j.1365-2249.1999.00918.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

2.  Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.

Authors:  A Pohl-Koppe; K E Balashov; A C Steere; E L Logigian; D A Hafler
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

3.  A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells.

Authors:  L Hviid; G Albeck; B Hansen; T G Theander; A Talbot
Journal:  J Immunol Methods       Date:  1993-01-04       Impact factor: 2.303

4.  Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major.

Authors:  K Kemp; L Hviid; A Kharazmi; M Kemp
Journal:  Scand J Immunol       Date:  1997-11       Impact factor: 3.487

5.  New perspectives on a subclinical form of visceral leishmaniasis.

Authors:  R Badaro; T C Jones; E M Carvalho; D Sampaio; S G Reed; A Barral; R Teixeira; W D Johnson
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

6.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

Authors:  P M Kaye; A J Curry; J M Blackwell
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

Authors:  E M Carvalho; R Badaró; S G Reed; T C Jones; W D Johnson
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.

Authors:  J Bahrenscheer; M Kemp; J A Kurtzhals; G S Gachihi; A Kharazmi; T G Theander
Journal:  APMIS       Date:  1995-02       Impact factor: 3.205

10.  Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections.

Authors:  A Gaafar; A Kharazmi; A Ismail; M Kemp; A Hey; C B Christensen; M Dafalla; A Y el Kadaro; A M el Hassan; T G Theander
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more
  16 in total

1.  Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.

Authors:  P Tripathi; S Ray; S Sunder; A Dube; S Naik
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine.

Authors:  Rajiv Kumar; Yasuyuki Goto; Kamlesh Gidwani; Karen D Cowgill; Shyam Sundar; Steven G Reed
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination.

Authors:  Barbara Papadopoulou; Gaétan Roy; Marie Breton; Christoph Kündig; Carole Dumas; Isabelle Fillion; Ajay K Singh; Martin Olivier; Marc Ouellette
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.

Authors:  Syamdas Bandyopadhyay; Amrita Bhattacharjee; Sayantan Banerjee; Kuntal Halder; Shibali Das; Bidisha Paul Chowdhury; Subrata Majumdar
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

5.  Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.

Authors:  P Khare; A K Jaiswal; C D P Tripathi; S Sundar; A Dube
Journal:  Clin Exp Immunol       Date:  2016-04-27       Impact factor: 4.330

6.  Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil.

Authors:  S E Jamieson; E N Miller; C S Peacock; M Fakiola; M E Wilson; A Bales-Holst; M-A Shaw; F Silveira; J J Shaw; S M Jeronimo; J M Blackwell
Journal:  Genes Immun       Date:  2006-11-23       Impact factor: 2.676

7.  Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment.

Authors:  Ludovic Donaghy; Florian Cabillic; Anne Corlu; Octavie Rostan; Olivier Toutirais; Christiane Guguen-Guillouzo; Claude Guiguen; Jean-Pierre Gangneux
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

8.  Subpopulations of bovine WC1(+) gammadelta T cells rather than CD4(+)CD25(high) Foxp3(+) T cells act as immune regulatory cells ex vivo.

Authors:  Aad Hoek; Victor P M G Rutten; Jolanda Kool; Ger J A Arkesteijn; Ruth J Bouwstra; Ildiko Van Rhijn; Ad P Koets
Journal:  Vet Res       Date:  2008-10-18       Impact factor: 3.683

9.  Regulation of adaptive immunity; the role of interleukin-10.

Authors:  T H Sky Ng; Graham J Britton; Elaine V Hill; Johan Verhagen; Bronwen R Burton; David C Wraith
Journal:  Front Immunol       Date:  2013-05-31       Impact factor: 7.561

10.  IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis.

Authors:  Benjamin M J Owens; Lynette Beattie; John W J Moore; Najmeeyah Brown; Jason L Mann; Jane E Dalton; Asher Maroof; Paul M Kaye
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.